XNK Therapeutics AB today announced that two posters, regarding bladder cancer and acute myeloid leukemia (AML) respectively, will be presented at the 20 th Meeting of the Society for Natural Immunity (NK2023) in Oslo, Norway , in September HUDDINGE, Sweden , Aug. 14, 2023 /PRNewswire/ — XNK Therapeutics will participate…Read More
XNK Therapeutics to present two posters at the NK2023 conference in Oslo in September
